ImpediMed
ImpediMed is the world leader in the development and distribution of medical devices employing bioimpedance spectroscopy (BIS) technologies for use in the non-invasive clinical assessment and monitoring of fluid status in patients. The fompany was founded in 1999 and is headquarted in Queensland, Australia.
Last updated on
About ImpediMed
Founded
1999Estimated Revenue
$1M-$10MEmployees
51-250Funding / Mkt. Cap
$72MCategory
Industry
Medical DevicesLocation
City
PinkenbaState
QueenslandCountry
AustraliaImpediMed
Find your buyer within ImpediMed